Skip to Main Content

Paper Details

Primary versus secondary gliosarcoma: a systematic review and meta-analysis.
Journal of Neuro-Oncology
5
2022
Bevacizumab, EGFR, EGFR mutation, Gliosarcomas, IDH, IDH mutation, MGMT, PGS, SGS, glioblastoma, gliosarcoma, malignant brain tumors, patients, primary gliosarcoma, secondary gliosarcoma, tumors
Author NameAffiliation
Ian F DunnOklahoma University Health Sciences Center
  • 1 - 1

Datasets

Release 1.2